Corporate Governance
AddLife´s group management
The CEO, Kristina Willgård, shall manage the operations in accordance with the Companies Act and within the framework established by the Board of Directors. The work and role of the CEO and the division of duties between the Board of Directors and the CEO are detailed in a written set of instructions set out by the Board of Directors (“Instructions to the CEO”). The Board of Directors continuously evaluates the work of the CEO. In consultation with the Chairman, the CEO has prepared the information needed to make decisions at Board meetings and has presented reports and reasoned proposals for decisions.
The CEO shall lead the work of the group management and make decisions in consultation with the other members of the group management. In addition to Kristina Willgård, group management also includes Martin Almgren, CFO and Business Area Manager Medtech, Peter Simonsbacka, Business Area Manager Labtech, Ulrika Hellman, Head of M&A and Ove Sandin, Senior Advisor. Martin Almgren will leave his position as CFO. Martin has during the year replaced Ove Sandin, previous Business Area Manager Medtech, who is now Senior Advisor. Christina Rubenhag has been reqruited as new CFO and will start her position during the second quarter 2022. Group management has regular business reviews under the management of the CEO.
Operational organisation
During the financial year, the Group’s operations were organised into two business areas – Labtech and Medtech. Operations are conducted in subsidiaries in the Nordic region, Central and Eastern Europe, Australia and China. Each operating Company has a board of directors in which the Company’s CEO and senior executives from the business area are represented. Each company president reports to a business division manager or business area manager, who, in turn reports to the CEO for AddLife AB.
KRISTINA WILLGÅRD
CEO
Born in: 1965
Member of Group Management since: 2015
Education: M.Sc. Econ
Professional experience: CFO Addtech AB, finance director Ericsson AB, CFO Netwise, CFO Frontec, Business controller Spendrups and Auditor Arthur Andersen
Other appointments: Member of the Board of Addnode Group AB and Mölnlycke AB
Holdings of shares in AddLife: 4,608 Class A shares and 415,052 Class B shares (including related party holdings) as well as call options corresponding with 290,600 Class B shares
MARTIN ALMGREN
CFO and Business Area Manager Medtech
Born in: 1976
Member of Group Management since: 2015
Education: M.Sc. Econ
Professional experience: Group Financial Controller Addtech AB, Group Accounting Manager Nefab AB, auditor EY
Holdings of shares in AddLife: 211,600 Class B shares as well as call options corresponding with 203,150 Class B shares
ULRIKA HELLMAN
Head of M&A
Born in: 1969
Member of Group Management since: 2021
Education: M.Sc. Econ
Professional experience: Strategy and M&A Sandvik Materials Technology AB, Client Executive Swedbank Large Corporates & Institutions, Head of TMT-team Swedbank Corporate Finance, Director Group M&A Telia Company, KPMG Corporate Finance, Analyst/Institution Broker SBC Warburg
Holdings of shares in AddLife: Call options corresponding with 17,000 Class B shares
PETER SIMONSBACKA
Business Area Manager Labtech
Born in: 1960
Member of Group Management since: 2017
Education: Engineer
Professional experience: Business area manager in Addtech Nordic AB, CEO BergmanLabora AB and Business area manager Mettler-Toledo AB
Other appointments: Chairman of the Board for Swedish Labtech
Holdings of shares in AddLife: 75,456 Class B shares as well as call options corresponding with 203,150 Class B shares
OVE SANDIN
Senior Advisor, former Business Area Manager Medtech
Born in: 1958
Member of Group Management since: 2019
Education: M.Sc. Engineering
Professional experience: CEO Triolab AB, Nordic Business Manager GN ReSound, CEO GN ReSound AB, Product Manager 3M, Engineer Thoracic medicine, Sahlgrenska University Hospital
Holdings of shares in AddLife: 15,512 Class B shares as well as call options corresponding with 153,000 Class B shares
Information regarding shareholdings as of 28 February 2022